RGD Reference Report - Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. - Rat Genome Database

RGD Reference Report - Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

General

Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Authors:	Bhavsar, NA Kottgen, A Coresh, J Astor, BC
Citation:	Bhavsar NA, etal., Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.
RGD ID:	7245503
Pubmed:	PMID:22542304 (View Abstract at PubMed)
PMCID:	PMC3399971 (View Article at PubMed Central)
DOI:	DOI:10.1053/j.ajkd.2012.02.336 (Journal Full-text)
BACKGROUND: Identifying individuals at risk of chronic kidney disease (CKD) is critical for timely treatment initiation to slow progression of the disease. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) are known biomarkers of acute kidney injury, but it is unknown whether these markers are associated with incident CKD stage 3 in the general population. STUDY DESIGN: Matched case-control study. SETTING & PARTICIPANTS: African American and white participants from the Atherosclerosis Risk in Communities (ARIC) Study who at baseline had an estimated glomerular filtration rate (eGFR) >/=60 mL/min/1.73 m(2) and urinary albumin-creatinine ratio /=25%). RESULTS: Both NGAL (P = 0.05) and KIM-1 levels (P < 0.001) were correlated positively with baseline urinary albumin-creatinine ratio; neither was associated with baseline eGFR. Participants with NGAL concentrations in the fourth quartile had more than 2-fold higher odds (adjusted OR, 2.11; 95% CI, 0.96-4.64) of incident CKD stage 3 compared with participants in the first quartile after multivariable adjustment (P-trend = 0.03). Adjustment for urinary creatinine and albumin levels resulted in a nonsignificant association (highest quartile adjusted OR, 1.52; 95% CI, 0.64-3.58; P = 0.2). No significant association between KIM-1 level and incident CKD was observed in crude or adjusted models. LIMITATIONS: The relatively small sample size of the study limits precision and power to detect weak associations. CONCLUSIONS: Higher NGAL, but not KIM-1, levels were associated with incident CKD stage 3. Adjustment for urinary creatinine and albumin concentration attenuated this association. Additional studies are needed to confirm these findings and assess the utility of urinary NGAL as a marker of CKD risk.

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Notes	Source	Original Reference(s)
LCN2	Human	end stage renal disease	onset	IEP		protein:increased expression:urine:	RGD
Lcn2	Rat	end stage renal disease	onset	ISO	LCN2 (Homo sapiens)	protein:increased expression:urine:	RGD
Lcn2	Mouse	end stage renal disease	onset	ISO	LCN2 (Homo sapiens)	protein:increased expression:urine:	RGD

Genes (Rattus norvegicus)


Lcn2 (lipocalin 2)

Genes (Mus musculus)


Lcn2 (lipocalin 2)

Genes (Homo sapiens)


LCN2 (lipocalin 2)